U.S. Markets open in 7 hrs 3 mins

BioCryst Pharmaceuticals, Inc. (BCRX)

NASDAQ Global Select - NASDAQ Global Select Delayed Price. Currency in USD
Add to watchlist
4.42+0.04 (+0.91%)
At close: 4:00PM EDT
People also watch
NVAXHEBVICLARRYAGEN
Full screen
Previous Close4.38
Open4.34
Bid0.00 x 0
Ask0.00 x 0
Day's Range4.31 - 4.53
52 Week Range3.75 - 9.25
Volume658,792
Avg. Volume1,492,114
Market Cap355.49M
Beta2.55
PE Ratio (TTM)-7.04
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Thomson Reuters StreetEvents12 days ago

    Edited Transcript of BCRX earnings conference call or presentation 7-Aug-17 3:00pm GMT

    Q2 2017 BioCryst Pharmaceuticals Inc Earnings Call

  • Associated Press16 days ago

    BioCryst reports 2Q loss

    The Durham, North Carolina-based company said it had a loss of 21 cents per share. The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research ...

  • Capital Cube22 days ago

    BioCryst Pharmaceuticals, Inc. – Value Analysis (NASDAQ:BCRX) : August 1, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives BioCryst Pharmaceuticals, Inc. a score of 34. Our analysis is based on comparing BioCryst Pharmaceuticals, Inc. with the following peers – Repligen Corporation, Sarepta Therapeutics, Inc., Novavax, Inc., Aviragen Therapeutics Inc, Celldex Therapeutics, Inc., Gilead Sciences, Inc., NanoViricides, Inc., CEL-SCI Corporation, Emergent BioSolutions Inc. and GlaxoSmithKline plc ... Read more (Read more...)